This inventor holds 1 USPTO granted patent. Top assignees: Celltrion Inc., Korea Disease Control and Prevention Agency. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Han-Saem Lee: Innovator in SARS-CoV-2 Neutralization
Introduction
Han-Saem Lee is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the fight against viral infections. His work focuses on developing innovative solutions to combat the SARS-coronavirus-2, the virus responsible for COVID-19.
Latest Patents
Han-Saem Lee holds a patent for a binding molecule that exhibits neutralizing activity against SARS-coronavirus-2. This invention relates to a binding molecule that specifically targets the spike protein (S protein) on the surface of the virus. The binding molecule demonstrates a strong ability to bind to SARS-CoV-2 and possesses high neutralizing activity, making it a valuable tool for the diagnosis, prevention, or treatment of SARS-coronavirus infection.
Career Highlights
Throughout his career, Han-Saem Lee has worked with prominent organizations such as the Korea Disease Control and Prevention Agency and Celltrion Inc. His experience in these institutions has allowed him to contribute to significant advancements in public health and biotechnology.
Collaborations
Han-Saem Lee has collaborated with esteemed colleagues, including Kyung-Chang Kim and Jun-Won Kim. Their joint efforts have furthered research and development in the field of viral neutralization.
Conclusion
Han-Saem Lee's innovative work in developing a binding molecule against SARS-CoV-2 highlights his commitment to advancing medical science. His contributions are crucial in the ongoing battle against COVID-19 and demonstrate the importance of innovation in public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile